Laguna Hills,  CA 
United States

For women diagnosed with DCIS, PreludeDx provides a proprietary molecular test (DCISionRT®) that predicts a woman’s personal likelihood or risk of developing DCIS recurrence in 10 years and invasive breast cancer in 10 years with or without adjuvant radiation therapy after breast conserving surgery. Visit